JPWO2020160022A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020160022A5 JPWO2020160022A5 JP2021543528A JP2021543528A JPWO2020160022A5 JP WO2020160022 A5 JPWO2020160022 A5 JP WO2020160022A5 JP 2021543528 A JP2021543528 A JP 2021543528A JP 2021543528 A JP2021543528 A JP 2021543528A JP WO2020160022 A5 JPWO2020160022 A5 JP WO2020160022A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 22
- 239000000427 antigen Substances 0.000 claims 13
- 102000036639 antigens Human genes 0.000 claims 13
- 108091007433 antigens Proteins 0.000 claims 13
- 239000012634 fragment Substances 0.000 claims 12
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 4
- 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 claims 3
- 101000737793 Homo sapiens Cerebellar degeneration-related antigen 1 Proteins 0.000 claims 3
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 3
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 3
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims 3
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 108010014419 Chemokine CXCL1 Proteins 0.000 claims 2
- 102000016950 Chemokine CXCL1 Human genes 0.000 claims 2
- 230000006229 amino acid addition Effects 0.000 claims 2
- 230000037430 deletion Effects 0.000 claims 2
- 238000012217 deletion Methods 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 210000004408 hybridoma Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962797573P | 2019-01-28 | 2019-01-28 | |
| US62/797,573 | 2019-01-28 | ||
| PCT/US2020/015457 WO2020160022A1 (en) | 2019-01-28 | 2020-01-28 | Compositions and methods for treatment of diseases involving cxcl1 function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022517865A JP2022517865A (ja) | 2022-03-10 |
| JPWO2020160022A5 true JPWO2020160022A5 (https=) | 2023-02-03 |
| JP2022517865A5 JP2022517865A5 (https=) | 2023-02-03 |
Family
ID=71841416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543528A Pending JP2022517865A (ja) | 2019-01-28 | 2020-01-28 | Ｃｘｃｌ１機能に関与する疾患の治療のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11292832B2 (https=) |
| EP (1) | EP3917949A4 (https=) |
| JP (1) | JP2022517865A (https=) |
| CN (1) | CN113544143A (https=) |
| CA (1) | CA3127943A1 (https=) |
| WO (1) | WO2020160022A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3249959A1 (en) * | 2022-01-27 | 2025-06-17 | Chiome Bioscience Inc. | ANTI-CXCL1 HUMAN ANTIBODY |
| WO2026060413A1 (en) * | 2024-09-16 | 2026-03-19 | Calgent Biotechnology Co., Ltd. | Single chain antibodies and use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910316B2 (en) * | 2005-09-02 | 2011-03-22 | Toray Industries, Inc. | Kit and method for detecting urothelial cancer |
| US7858752B2 (en) | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
| CN101261275A (zh) * | 2008-01-23 | 2008-09-10 | 李力 | 一种用于早期卵巢癌诊断的检测试剂盒 |
| WO2010050552A1 (ja) | 2008-10-29 | 2010-05-06 | 日本ゼオン株式会社 | ニトリル共重合体ラテックス組成物およびニトリル共重合体ゴム組成物 |
| KR101682257B1 (ko) | 2008-10-31 | 2016-12-05 | 도레이 카부시키가이샤 | 인간 ｃｘｃｌ１ 단백질의 면역학적 측정 방법 |
| US8900588B2 (en) | 2010-01-08 | 2014-12-02 | Les Laboratories Servier | Methods for treating breast cancer |
| WO2014113804A1 (en) * | 2013-01-21 | 2014-07-24 | Abbvie Inc. | Anti-tnf and anti-il17 combination therapy biomarkers for inflammatory disease |
| US9290570B2 (en) | 2013-03-15 | 2016-03-22 | Eli Lilly And Company | Pan-ELR+ CXC Chemokine Antibodies |
| EP2997042B1 (en) | 2013-05-17 | 2019-08-07 | Centre National de la Recherche Scientifique (CNRS) | Anti-cxcl1, cxcl7 and cxcl8 antibodies and their applications |
| WO2019055776A2 (en) * | 2017-09-14 | 2019-03-21 | Rosser Charles | COMPOSITIONS AND METHODS FOR TREATING DISEASES INVOLVING CXCL1 FUNCTION |
| US11603569B2 (en) * | 2018-03-20 | 2023-03-14 | Cedars-Sinai Medical Center | Immune modulating genes for prognosis, diagnosis and treatment of metastatic disease, and drug identification methods thereof |
-
2020
- 2020-01-28 US US16/982,456 patent/US11292832B2/en active Active
- 2020-01-28 EP EP20747679.7A patent/EP3917949A4/en active Pending
- 2020-01-28 WO PCT/US2020/015457 patent/WO2020160022A1/en not_active Ceased
- 2020-01-28 CA CA3127943A patent/CA3127943A1/en active Pending
- 2020-01-28 CN CN202080017507.1A patent/CN113544143A/zh active Pending
- 2020-01-28 JP JP2021543528A patent/JP2022517865A/ja active Pending
-
2022
- 2022-03-07 US US17/688,740 patent/US11760796B2/en active Active
-
2023
- 2023-08-18 US US18/451,872 patent/US20240018229A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024038003A5 (https=) | ||
| JP2020508655A5 (https=) | ||
| JP2012525829A5 (https=) | ||
| JP2020514277A5 (https=) | ||
| JP2023093753A5 (https=) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2021530244A5 (https=) | ||
| JP2024105229A5 (https=) | ||
| JP2021520832A5 (https=) | ||
| JP2024024114A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JP2020513759A5 (https=) | ||
| JP2022500455A5 (https=) | ||
| CN111712521A (zh) | Cd38蛋白抗体及其应用 | |
| IL316226A (en) | Anti-ror1 antibody and ror1-targeting engineered cells | |
| RU2010122044A (ru) | УЛУЧШЕННЫЕ МОЛЕКУЛЫ, СВЯЗЫВАЮЩИЕСЯ С Nogo-А И ИХ ФАРМАЦЕВТИЧЕСКОЕ ПРИМЕНЕНИЕ | |
| JP2021176829A5 (https=) | ||
| JPWO2022111425A5 (https=) | ||
| JP2021518748A5 (https=) | ||
| JPWO2020023644A5 (https=) | ||
| JP2025130076A5 (https=) | ||
| JPWO2020028428A5 (https=) | ||
| JP2021514369A5 (https=) | ||
| JPWO2021207072A5 (https=) | ||
| JPWO2020160022A5 (https=) |